IXICO PLC announced a 23% increase in revenues and a 38% growth in its order book, driven by strong demand in Alzheimer’s disease clinical trials and new contracts in diagnostics. CEO Bram Goorden highlighted the company’s TechBio strategy, supported by a recent £10 million capital raise, aimed at productizing their IXI technology platform to enhance automation and scalability. The company is expanding geographically, especially in the US and Asia, while maintaining momentum in its imaging CRO business. With 95% of 2026 revenues secured, IXICO expects continued growth focused on neurodegenerative diseases and technology-driven recurring revenues.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
In 2026, Alphabet has delivered outstanding returns over one, three, and five years, contrasting with struggles faced by other hyperscalers. The semiconductor sector remains highly cyclical, impacting both business performance and stock prices. A com...
IES Holdings has been upgraded to a Buy rating due to a record backlog increase of 63% to $3.9 billion and ongoing capacity expansion. The company’s Communications and Infrastructure Solutions segments, which have higher margins and growth potential,...
Taiwan Semiconductor Manufacturing Company (TSMC) reported a 23.4% increase in second-quarter profit from the previous quarter, surpassing analyst estimates. The company's net income reached NT$706.56 billion ($39.45 billion), a record high for the f...
National Beverage faces stagnant growth as LaCroix volumes have declined for four straight years, reducing brand excitement. The stock trades at reasonable multiples reflecting muted growth and no clear catalysts for upside. Despite stable gross marg...
